4001ÀϰٻãÍøÕ¾

±±¾©»ùÒò×éËù£¨¹ú¼ÒÉúÎïÐÅÏ¢ÖÐÐÄ£©ºÏ×÷Õ¹ÏÖ¶ùͯ°×Ѫ²¡¸É/×æÏ¸°ûµÄÒìÖÊÐÔ¼°»¯ÁÆÄÍÒ©µÄ¸Éϸ°ûÑÇȺ

¡¡¡¡¼±ÐÔËèϵ°×Ѫ²¡£¨acute myeloid leukemia, AML£©ÊÇÒ»ÖÖ¶ñÐÔѪҺÖ×Áö£¬Í¨³£ÓÉÓÚËèϵÔìѪ¸É/×æÏ¸°û·Ö½âÊÜ×è¶øÒýÆð¡£AML²¡³ÌÏ£ÍûѸËÙ¡¢ÖÎÓúÂʽϵÍ¡£¾Ýͳ¼Æ£¬¶ùͯ»¼ÕßµÄÎåÄêÎÞ²¡ÉúÑÄÂʽöÔ¼50%¡£»¯ÁÆÊÇAMLµÄÖ÷ÒªÖÎÁÆÒªÁìÖ®Ò»£¬ÄÜÏÔÖøïÔÌ­Ö×Áöϸ°ûÊýÄ¿£¬Ê¹»¼Õߵִﻺ½â£¬µ«ÈÔÓÐһС²¿·ÖÖ×Áöϸ°û²ÐÁô£¬¿ÉÄܳÉΪÒýÆð¼²²¡¸´·¢µÄÖÖ×Ó¡£ËäÈ»»ùÓÚ»ùÒòÍ»±äµÄÒªÁì¿ÉÒÔѸËٵؼì²â²ÐÁôϸ°û£¬µ«ÒªÆÊÎö»º½âÆÚ²ÐÁôµÄ°×Ѫ²¡Ï¸°ûµÄÉúÎïÑ§ÌØÕ÷È´ÃæÁÙÖØ´óÌôÕ½¡£ÁÙ´²ÉÏҲһֱȱ·¦ÌØÒìÐÔµÄÒªÁìÓÃÓÚÕï¶Ï¡¢¼à²âºÍɨ³ýÕâЩϸ°û¡£

¡¡¡¡¾Û½¹ÓÚÉÏÊöÁÙ´²ÎÊÌ⣬4001ÀϰٻãÍøÕ¾£¨¹ú¼ÒÉúÎïÐÅÏ¢ÖÐÐÄ£©µÄÍõǰ·ÉÍŶÓÓëËÕÖÝ´óѧÁ¥Êô¶ùͯҽԺµÄºúÉÜÑàÍŶӺÏ×÷£¬ÒÀÍÐÓÚ¶ùͯAMLµÍ¼ÁÁ¿»¯ÁÆÍŽáG-CSFÈýÆÚËæ»ú±ÈÕÕ¶àÖÐÐÄÁÙ´²ÊÔÑé(CALS III-AML18)£¬Í¨Ï꾡ÄåÆÊÎö»¼Õß»¯ÁÆÇ°ºó¹ÇËèµÄÒìÖÊÐÔϸ°ûȺÌ壬²¢ÍŽáÁÙ´²´óÑù±¾ÐÐÁÐÑéÖ¤ºÍ¹¦Ð§ÊµÑ飬Ê×´ÎÃè»æÁ˶ùͯAML»¯Áƺó²ÐÁôÖ×Áöϸ°ûµÄµ¥Ï¸°ûת¼×éͼÆ×¡£¸ÃÑо¿Ã÷È·ÁË»¼ÕßÌåÄڵİ×Ѫ²¡¸Éϸ°û£¨leukemia stem cell, LSC£©ºÍÑõ»¯Á×Ëữ(oxidative phosphorylation, OXPHOS)Á½¸öÄÍÒ©ÌØÕ÷¼°Æä¶ÔÓ¦µÄ׼ȷϸ°ûÑÇȺ£¬·¢Ã÷ÁËÄÍÒ©µÄHSC-like¸Éϸ°ûÑÇȺ¼°ÆäÍâò±ê¼ÇÎïCD69£¬²¢ÆðÔ´Õ¹ÏÖÁËCD69ͨ¹ýµ÷¿ØmTOR-CCND1-CXCR4Öá½éµ¼ÄÍÒ©µÄ·Ö×Ó»úÖÆ¡£Ñо¿»¹·¢Ã÷¸Ã¸Éϸ°ûÄÍÒ©ÑÇȺµÄϸ°û±ÈÀý¸ßÓëÔ¤ºó²»Á¼µÄÁÙ´²±íÐͺͻùÒò×éÌØÕ÷Ïà¹Ø¡£ÕâЩÊìϤΪÁÙ´²Õï¶ÏºÍ¼à²âÌṩÁËÖ÷ÒªµÄÀíÂÛÒÀ¾Ý¡£¸ÃЧ¹ûÒÔ¡±Single-cell transcriptomics reveals multiple chemoresistant properties in leukemic stem and progenitor cells in pediatric AML¡±ÎªÌ⣬ÓÚ2023Äê8ÔÂ31ÈÕ½ÒÏþÔÚGenome Biology ÆÚ¿¯¡£

¡¡¡¡4001ÀϰٻãÍøÕ¾£¨¹ú¼ÒÉúÎïÐÅÏ¢ÖÐÐÄ£©Íõǰ·ÉÑо¿Ô±¡¢ËÕÖÝ´óѧÁ¥Êô¶ùͯҽԺµÄºúÉÜÑàÖ÷ÈÎΪ±¾ÎĵÄÅäºÏͨѶ×÷Õߣ¬4001ÀϰٻãÍøÕ¾£¨¹ú¼ÒÉúÎïÐÅÏ¢ÖÐÐÄ£©²©Ê¿½áÒµÉú½­æ­æÃºÍ¸±Ñо¿Ô±ºÍ·òºì£¬ÒÔ¼°ËÕÖÝ´óѧÁ¥Êô¶ùͯҽԺ²©Ê¿½áÒµÉúÕÅÓÀƽºÍ²©Ê¿ºóÌï԰԰ΪÎÄÕµÄÅäºÏµÚÒ»×÷Õß¡£¸ÃÑо¿»ñµÃÁ˿Ƽ¼²¿ÖصãÑз¢ÍýÏë¡¢¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ð¡¢½­ËÕÊ¡¡¢4001ÀϰٻãÍøÕ¾µÈÏîÄ¿µÄ×ÊÖú¡£

4001Àϰٻãnet(¼¯ÍÅ)NO.1¹Ù·½ÍøÕ¾

¶ùͯ°×Ѫ²¡¸É/×æÏ¸°ûµÄÒìÖÊÐÔ¼°»¯ÁÆÄÍÒ©µÄ¸Éϸ°ûÑÇȺ

¡¡¡¡ÂÛÎÄÁ´½Ó

¸½¼þÏÂÔØ£º
ÍøÕ¾µØÍ¼